Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Tesar

Showing results (131-140 of 193) with videos related to

Pageof 20
Sort By:
RMD Open|April 30, 2024
Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitisJennifer Scott, Arthur White, Cathal Walsh, et al.
Lancet (London, England)|April 2, 2017
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trialBengt C Fellström, Jonathan Barratt, Heather Cook, et al.
Annals of the Rheumatic Diseases|December 1, 2011
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-upLorraine Harper, Matthew D Morgan, Michael Walsh, et al.
Annals of the Rheumatic Diseases|August 26, 2010
Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment IndexRavi Suppiah, Oliver Flossman, Chetan Mukhtyar, et al.
The New England Journal of Medicine|July 4, 2003
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodiesDavid Jayne, Niels Rasmussen, Konrad Andrassy, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 10, 2023
Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendationsMarta Casal Moura, Philipp Gauckler, Hans-Joachim Anders, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2014
Building a network of ADPKD reference centres across Europe: the EuroCYST initiativeKatja Petzold, Ron T Gansevoort, Albert C M Ong, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2020
Urine proteomics for prediction of disease progression in patients with IgA nephropathyMichael Rudnicki, Justyna Siwy, Ralph Wendt, et al.
Kidney International Supplements|December 11, 2020
Corrigendum to "Tonelli M, Nkunu V, Varghese C, et al. Framework for establishing integrated kidney care programs in low- and middle-income countries" <i>Kidney Int Suppl.</i> 2020;10:e19-e23Marcello Tonelli, Victoria Nkunu, Cherian Varghese, et al.
Nature Communications|January 28, 2023
Next-Generation Morphometry for pathomics-data mining in histopathologyDavid L Hölscher, Nassim Bouteldja, Mehdi Joodaki, et al.
Pageof 20

Showing results (131-140 of 193) with videos related to

Sort By:
Pageof 20
RMD Open|April 30, 2024
Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitisJennifer Scott, Arthur White, Cathal Walsh, et al.
Lancet (London, England)|April 2, 2017
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trialBengt C Fellström, Jonathan Barratt, Heather Cook, et al.
Annals of the Rheumatic Diseases|December 1, 2011
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-upLorraine Harper, Matthew D Morgan, Michael Walsh, et al.
Annals of the Rheumatic Diseases|August 26, 2010
Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment IndexRavi Suppiah, Oliver Flossman, Chetan Mukhtyar, et al.
The New England Journal of Medicine|July 4, 2003
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodiesDavid Jayne, Niels Rasmussen, Konrad Andrassy, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 10, 2023
Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendationsMarta Casal Moura, Philipp Gauckler, Hans-Joachim Anders, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2014
Building a network of ADPKD reference centres across Europe: the EuroCYST initiativeKatja Petzold, Ron T Gansevoort, Albert C M Ong, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2020
Urine proteomics for prediction of disease progression in patients with IgA nephropathyMichael Rudnicki, Justyna Siwy, Ralph Wendt, et al.
Kidney International Supplements|December 11, 2020
Corrigendum to "Tonelli M, Nkunu V, Varghese C, et al. Framework for establishing integrated kidney care programs in low- and middle-income countries" <i>Kidney Int Suppl.</i> 2020;10:e19-e23Marcello Tonelli, Victoria Nkunu, Cherian Varghese, et al.
Nature Communications|January 28, 2023
Next-Generation Morphometry for pathomics-data mining in histopathologyDavid L Hölscher, Nassim Bouteldja, Mehdi Joodaki, et al.
Pageof 20